Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Scottish CMO Symbiosis strengthens US presence Scottish CMO Symbiosis strengthens US presence Scottish CMO Symbiosis strengthens US presence Appoints Dr Thomas Scullion as US Business Development Manager David Lescuyer joins SkyePharma as Executive Vice President, Oral Business David Lescuyer joins SkyePharma as Executive Vice President, Oral Business He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Appointments bring internationally recognised expertise to strengthen Kymab’s key therapeutic areas Adapt Pharma names Mike Kelly as President of US operations Adapt Pharma names Mike Kelly as President of US operations He contributes more than 25 years of pharmaceutical expertise to Adapt executive team Dr Richard Butt to become CEO of Apollo Therapeutics Dr Richard Butt to become CEO of Apollo Therapeutics He will join the investment fund from Pfizer Neusentis Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Quinn has been Chief Medical Officer of the organisation for the past six months Nigel Bond joins Brother executive management team Nigel Bond joins Brother executive management team Nigel Bond joins Brother executive management team Follows acquisition of Domino Printing Sciences by Japanese firm Merck appoints Maya Martinez-Davis as Global Head of Oncology Merck appoints Maya Martinez-Davis as Global Head of Oncology Merck appoints Maya Martinez-Davis as Global Head of Oncology Her role will include defining global oncology strategies and delivering therapeutic launches President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest Susanne Resatz will help GACC Midwest further promote and expand bilateral trade and investment between the Midwest and Germany Probiodrug appoints Mark Booth as Chief Business Officer Probiodrug appoints Mark Booth as Chief Business Officer The move expands the German firm's Management Board Novavax announces management promotion Novavax announces management promotion Iksung Cho has been named as Vice President, Biostatistics Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development He will lead all global R&D across the oncology therapeutic area New Technical Officer for ReFaC New Technical Officer for ReFaC New Technical Officer for ReFaC Kim Shillington joins the UK firm ESMO appoints first Chief Medical Officer ESMO appoints first Chief Medical Officer ESMO appoints first Chief Medical Officer New position reflects ESMO’s rapid growth and follows extensive six-month selection process Paragon Bioservices appoints Bill Thomas as Chief Technology Officer Paragon Bioservices appoints Bill Thomas as Chief Technology Officer Vaccines industry veteran was most recently with MassBiologics Cypralis hires Dr Michael Peel as Chief Scientific Officer Cypralis hires Dr Michael Peel as Chief Scientific Officer He joins the UK life sciences firm from Scynexis, where he was Director of Discovery
  • Previous
  • 1
  • …
  • 99
  • 100
  • 101
  • 102 (current)
  • 103
  • 104
  • 105
  • …
  • 216
  • Next

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy